logo_web
  • Clinical Trials
    • Management of medication
    • Management of reimbursement of expenses to patients
    • Supply of medical devices
    • Destruction
    • Calibration of medical devices
    • Import and labeling of medication
    • Masking. Placebos manufacturing
  • Blog
  • Quality
    • Certifications
    • RSE
  • Clients
  • Patient Reimbursement Forms
    • Validation / Expense Reimbursement Sheet
✕
  • Clinical Trials
    • Management of medication
    • Management of reimbursement of expenses to patients
    • Supply of medical devices
    • Destruction
    • Calibration of medical devices
    • Import and labeling of medication
    • Masking. Placebos manufacturing
  • Blog
  • Quality
    • Certifications
    • RSE
  • Clients
  • Patient Reimbursement Forms
    • Validation / Expense Reimbursement Sheet
7 May, 2026

Ten key points for maintaining competitiveness in Europe

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has issued a ten-point plan ahead of the meeting of heads of state in Belgium next Thursday […]
Like?
Leer más
5 May, 2026

Spain attracts hundreds of clinical trials, offering a last hope to thousands of patients: “Without research, we are lost”

Our country is establishing itself as a hub for clinical research, thanks to its public healthcare system: in 2025 alone, more than 900 trials were authorised […]
Like?
Leer más
4 May, 2026

FDA inspections uncover recurring shortcomings in clinical trials worldwide

A study has revealed similar patterns of non-compliance across different countries and calls into question the actual scope of supervision consalud.es A recent analysis published in […]
Like?
Leer más
30 April, 2026

The FDA is launching a pilot programme to monitor clinical trials in real time

The initiative aims to speed up the approval of medicines, reduce the administrative burden and boost competitiveness against China consalud.es The US Food and Drug Administration […]
Like?
Leer más
29 April, 2026

Fina Lladós: “Europe must take action to avoid falling behind in biomedical research and access to the most innovative medicines”

Farmaindustria held its Annual General Meeting in Madrid on Thursday, during which the Association’s president warned of the risks and uncertainties affecting the sector due to […]
Like?
Leer más
28 April, 2026

The US and China are stepping up the race for global pharmaceutical innovation

An analysis of the scientific literature reveals how geopolitical competition and R&D models are reshaping drug development and access to healthcare consalud.es Pharmaceutical innovation has established […]
Like?
Leer más
27 April, 2026

Experimental drugs: between innovation and clinical uncertainty

The role of applications for new medicines in research and the strategic use of experimental treatments consalud.es The development of investigational drugs is one of the […]
Like?
Leer más
20 April, 2026

The high cost of pharmaceutical failure: when a failed trial affects the entire business strategy

A recent study reveals that failures in drug development not only reduce future revenue, but also affect mergers, market value and investor confidence consalud.es The cost […]
Like?
Leer más
17 April, 2026

The FDA warns that 30% of clinical trials in the US do not report their results

The regulator is stepping up pressure on the pharmaceutical and scientific industries to improve transparency consalud.es The FDA has sounded the alarm over a lack of […]
Like?
Leer más
16 April, 2026

How the geopolitical situation is affecting medicines in Spain

The development of a new medicine is a long, complex and high-risk process. Every new treatment—from a therapy for diabetes to a drug for a rare […]
Like?
Leer más
14 April, 2026

Spain is stepping up the pace in the long-term race for clinical trials

lavanguardia.com Before finally agreeing to her doctor’s proposal, Cecilia Rodríguez had undergone chemotherapy, radiotherapy and immunotherapy. The cancer she had been living with for six years […]
Like?
Leer más
9 April, 2026

Fortrea is driving the digitalisation of clinical trials with an AI-powered platform

The new FIT solution aims to automate processes, improve decision-making and boost efficiency in clinical development Consalud.es Fortrea has announced the launch of Fortrea Intelligent Technology […]
Like?
Leer más
123456789101112131415161718192021222324252627
Next page

CENTRAL

Pol. PIBO. Avda. de Gines, 14
+34 955 776 767 /+34 692 454 913
41110 Bollullos de la Mitación (Sevilla)

DELEGACIÓN MADRID

+34 674 575 115
28010 Madrid

Enlaces de interés

  • Legal warning
  • Privacy policy
  • Cookies policy
  • Contact

© 2026 Distefar del Sur SL. Todos los derechos reservados. agencianodo.com

    [recaptcha]

    In accordance with the provisions of Regulation (EU) 2016/679 and Organic Law 3/2018 regarding Data Protection, we inform you that the data you provide in this form will be incorporated into a file owned by DISTEFAR DEL SUR, SL domiciled in the C / Umbrete 58, (Pol. Ind. Pibo), 41110 of Bollullos de la Mitación (Seville), in order to manage your request.

    In this regard, and if you wish to exercise your rights of access, rectification, cancellation, opposition, portability and limitation, please send a written communication to DISTEFAR DEL SUR, SL, to the address indicated above or to info@distefar.com, attaching copy of your National Identity Document or equivalent identification document.

    Basic information about Data Protection

     Epigraph

    Basic information Data Protection

    Responsable

    DISTEFAR DEL SUR, S.L.

    Purpose

    Process your inquiry / request
    Detailed information on Data Protection

    Legitimation

    Consent
    Detailed information on Data Protection

    Recipients

    It is not expected to carry out data communications to third parties, except legal obligation
    Transfers of data to third countries outside the European Union will not be carried out
    Detailed information on Data Protection

    Rights

    You have the right of access, rectification, deletion, portability of your data, as well as limitation or opposition to your treatment, as detailed in Detailed information on Data Protection

    Additional Information

    You can consult the additional and detailed information on data protection by clicking here Detailed information on Data Protection

    All the data requested / The fields marked with * in the form are mandatory, if not filled in DISTEFAR DEL SUR, S.L. will not be able to meet your request.

    Distefar del Sur
    Gestión de la medicación Reembolso de gastos a pacientes Suministro de dispositivos médicos Destrucción Calibración de dispositivos médicos Importación y etiquetado Enmascaramiento. Fabricación de placebos
    Blog
    Certificaciones RSE
    Clientes
    Hoja de Validación / Reembolso de Gastos
    Contactar
    +34 955 776 767 info@distefar.com
    ES ES EN EN